PEPID International

pepidinternational.com

PEPID International products enable doctors, nurses and students to carry advanced medical and drug information resources to the point of care, wherever that may be. Delivered on Smartphones, online and by enterprise information systems, PEPID International products feature internationally comprehensive drug databases, a full spectrum of medical topics, and clinical tools such as a drug interactions generator and thousands of dosing calculators. These resources help caregivers provide more accurate care and avoid adverse events.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CIGNA, HUMANA, OTHER INSURERS, WAIVE COSTS FOR COVID-19 TREATMENT

Healthcare Finance News | March 31, 2020

news image

Cigna and Humana are joining other insurers in waiving costs for COVID-19 treatment. Cigna is waiving cost-sharing and co-payments through May 31. Humana is waiving costs for treatment related to COVID-19 and is now covering subsequent treatment, including inpatient hospital admissions. Humana will cover the member responsibility under the plan benefits for COVID-19-related services, whether treatment is delivered by in-network or out-of-network providers. ...

Read More

FUTURE OF HEALTHCARE

SPECTRUM SCIENCE ACQUIRES THE SEISMIC COLLABORATIVE, DEEPENING EXPERTISE IN EMERGING INNOVATION AND HEALTH TECHNOLOGY

Spectrum Science | June 10, 2022

news image

Spectrum Science, an independent, integrated marketing, communications and media agency hyper-focused on health and science, announced the acquisition of The Seismic Collaborative, an independent health and life science agency that specializes in supporting early-stage health tech and biotech companies. The Seismic acquisition establishes the Emerging Innovation Group within Spectrum, a new offering that expands the agency's capabilities to deliver at all points of a company and product l...

Read More

FUTURE OF HEALTHCARE

GENEQUANTUM AND AIMEDBIO COLLABORATE ON A FIRST-IN-CLASS ANTIBODY -DRUG-CONJUGATE

GeneQuantum Healthcare | April 19, 2022

news image

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQ...

Read More

HEALTH TECHNOLOGY

FRANCISCO PARTNERS LAUNCHES DATA COMPANY MERATIVE AFTER ACQUIRING IBM’S HEALTHCARE DATA AND ANALYTICS ASSETS

Francisco Partners and Merative | July 01, 2022

news image

The acquisition of the healthcare data and analytics assets that were a part of IBM's Watson Health business, has been completed, according to Francisco Partners, a renowned international investment firm that specializes in working with technology companies. The new standalone business, which will be owned by Francisco Partners, will be known as Merative and have its headquarters in Ann Arbor, Michigan. Merative serves clients in the life sciences, provider, imaging, h...

Read More
news image

CIGNA, HUMANA, OTHER INSURERS, WAIVE COSTS FOR COVID-19 TREATMENT

Healthcare Finance News | March 31, 2020

Cigna and Humana are joining other insurers in waiving costs for COVID-19 treatment. Cigna is waiving cost-sharing and co-payments through May 31. Humana is waiving costs for treatment related to COVID-19 and is now covering subsequent treatment, including inpatient hospital admissions. Humana will cover the member responsibility under the plan benefits for COVID-19-related services, whether treatment is delivered by in-network or out-of-network providers. ...

Read More
news image

FUTURE OF HEALTHCARE

SPECTRUM SCIENCE ACQUIRES THE SEISMIC COLLABORATIVE, DEEPENING EXPERTISE IN EMERGING INNOVATION AND HEALTH TECHNOLOGY

Spectrum Science | June 10, 2022

Spectrum Science, an independent, integrated marketing, communications and media agency hyper-focused on health and science, announced the acquisition of The Seismic Collaborative, an independent health and life science agency that specializes in supporting early-stage health tech and biotech companies. The Seismic acquisition establishes the Emerging Innovation Group within Spectrum, a new offering that expands the agency's capabilities to deliver at all points of a company and product l...

Read More
news image

FUTURE OF HEALTHCARE

GENEQUANTUM AND AIMEDBIO COLLABORATE ON A FIRST-IN-CLASS ANTIBODY -DRUG-CONJUGATE

GeneQuantum Healthcare | April 19, 2022

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQ...

Read More
news image

HEALTH TECHNOLOGY

FRANCISCO PARTNERS LAUNCHES DATA COMPANY MERATIVE AFTER ACQUIRING IBM’S HEALTHCARE DATA AND ANALYTICS ASSETS

Francisco Partners and Merative | July 01, 2022

The acquisition of the healthcare data and analytics assets that were a part of IBM's Watson Health business, has been completed, according to Francisco Partners, a renowned international investment firm that specializes in working with technology companies. The new standalone business, which will be owned by Francisco Partners, will be known as Merative and have its headquarters in Ann Arbor, Michigan. Merative serves clients in the life sciences, provider, imaging, h...

Read More